Key Record Dates
ClinicalTrials.gov Identifier: | NCT03433183 |
---|---|
Brief Title: | SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors |
First Submitted : | January 29, 2018 |
First Submitted that Met QC Criteria : | February 7, 2018 |
First Posted : | February 14, 2018 |
Last Update Submitted that Met QC Criteria : | December 22, 2023 |
Last Update Posted : | December 26, 2023 |